CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback

CVS re-adds BMS, Pfizer's Eliquis to formulary after tough negotiations, patient pushback

Source: 
Fierce Pharma
snippet: 

After months of tough negotiations and pushback from patients and doctors, CVS Health is adding the popular blood thinner Eliquis back to its national preferred formulary. For months, patients had been left with two options—make the switch to Johnson & Johnson's rival blood thinner Xarelto or pay for Eliquis completely out of pocket.